RAPP
Rapport Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$45.77
−3.95%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.13x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 0.36x
Liquidity & coverage
- Current ratio
- 15.72x
- Quick ratio
- 15.72x
- Cash ratio
- 15.34x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $418.4M
Cash & dividend
- FCF / debt
- -9.61x
- Cash flow / debt
- -9.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026